Tenofovir disoproxil fumarate SOF/VEL 750

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1 dose
300 mg once daily
Drug 1 effect

Cmax increased 36%; AUC increased 35%; Cmin increased 45%

Drug 2 dose
400 / 100mg once daily
Drug 2 effect

Not studied

Clinical Effects

Potentially increased risk of TDF adverse effects (e.g. renal function decline)

Management

If coadministering, monitor for TDF adverse effects

Import ID
750